Three domestically produced Covid-19 vaccines will be ready for administration by next year, the government announced on the Thai Khu Fah Facebook page.
The first vaccine, CU-Cov19 (mRNA), is being developed in collaboration with Chulalongkorn University’s Faculty of Medicine and the University of Pennsylvania, and is currently in the human-trial phase.
The second, HXP-GPO Vac (inactivated), is developed by the Government Pharmaceutical Organization in collaboration with Mahidol University and the United States’ PATH Institute. It is also currently in the human-trial phase.
The last one, Baiya SARS-CoV-1 Vax 1, is developed from tobacco leaves by Baiya Phytopharm and Chulalongkorn University. This vaccine has been successfully tested on animals and will soon be tried out on humans.
The announcement comes a day after the government said a potential Covid-19 vaccine, derived from plant protein that uses the same technology as an as-yet-unapproved vaccine from Novavax Inc. could be ready for production in a few weeks.